Literature DB >> 28785929

Synthesis of novel 7-aryl and 7-spiropyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine derivatives and their study as AChE inhibitors.

Paola Acosta1, Braulio Insuasty1, Rodrigo Abonia1, Margarita Gutierrez2, Jairo Quiroga3.   

Abstract

An efficient route for the synthesis of novel 7-aryl and 7-spiropyrazolo[4[Formula: see text],3[Formula: see text]:5,6]pyrido[2,3-d]pyrimidine derivatives is described. These compounds were obtained by a cyclocondensation reaction between pyrazolopyridinediamines 4 and aldehydes 5 or cyclic ketones 6 in the presence of acetic acid as catalyst. This procedure provides the desired compounds in good yields under a simple two-step methodology. The obtained compounds were evaluated as AChE inhibitors and showed weak AChe inhibition with [Formula: see text].

Entities:  

Keywords:  Aromatic aldehydes; Cyclic ketones; Cyclocondensation reaction; Pyrazolopyridines; Pyrimidines; Spiropyrimidines

Mesh:

Substances:

Year:  2017        PMID: 28785929     DOI: 10.1007/s11030-017-9774-3

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  21 in total

1.  Impregnated copper on magnetite: an efficient and green catalyst for the multicomponent preparation of propargylamines under solvent free conditions.

Authors:  María J Aliaga; Diego J Ramón; Miguel Yus
Journal:  Org Biomol Chem       Date:  2009-11-16       Impact factor: 3.876

2.  The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project.

Authors:  A Wimo; L Jönsson; A Gustavsson; D McDaid; K Ersek; J Georges; L Gulácsi; K Karpati; P Kenigsberg; H Valtonen
Journal:  Int J Geriatr Psychiatry       Date:  2010-10-28       Impact factor: 3.485

3.  Pyrido[2,3-d]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4.

Authors:  Scott N VanderWel; Patricia J Harvey; Dennis J McNamara; Joseph T Repine; Paul R Keller; John Quin; R John Booth; William L Elliott; Ellen M Dobrusin; David W Fry; Peter L Toogood
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

4.  Synthesis and pharmacological assessment of diversely substituted pyrazolo[3,4-b]quinoline, and benzo[b]pyrazolo[4,3-g][1,8]naphthyridine derivatives.

Authors:  Daniel Silva; Mourad Chioua; Abdelouahid Samadi; M Carmo Carreiras; María-Luisa Jimeno; Eduarda Mendes; Cristóbal de Los Ríos; Alejandro Romero; Mercedes Villarroya; Manuela G López; José Marco-Contelles
Journal:  Eur J Med Chem       Date:  2011-06-07       Impact factor: 6.514

5.  Convenient synthesis of novel 4-substitutedamino-5-trifluoromethyl-2,7-disubstituted pyrido[2,3-d] pyrimidines and their antibacterial activity.

Authors:  S Ravi Kantha; G Venkat Reddy; K Hara Kishore; P Shanthan Rao; B Narsaiaha; U Surya Narayana Murthy
Journal:  Eur J Med Chem       Date:  2006-08       Impact factor: 6.514

Review 6.  The cholinergic hypothesis of Alzheimer's disease: a review of progress.

Authors:  P T Francis; A M Palmer; M Snape; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

7.  Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial and antifungal agents.

Authors:  Khalid Mohammed Hassan Hilmy; Maha M A Khalifa; Mohammed Abd Allah Hawata; Reda Mohammed Aboalzeen Keshk; Abd Almeneam el-Torgman
Journal:  Eur J Med Chem       Date:  2010-08-24       Impact factor: 6.514

8.  The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells.

Authors:  J F Dorsey; R Jove; A J Kraker; J Wu
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

9.  Pyridopyrimidine derivatives as inhibitors of cyclic nucleotide synthesis: Application for treatment of diarrhea.

Authors:  Alexander Y Kots; Byung-Kwon Choi; Maria E Estrella-Jimenez; Cirle A Warren; Scott R Gilbertson; Richard L Guerrant; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-16       Impact factor: 11.205

10.  Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.

Authors:  Abdul Hameed; Syeda T Zehra; Syed J A Shah; Khalid M Khan; Rima D Alharthy; Norbert Furtmann; Jürgen Bajorath; Muhammad N Tahir; Jamshed Iqbal
Journal:  Chem Biol Drug Des       Date:  2015-05-28       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.